Position in ROIV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$884,573
-$5,982 QoQ
Shares Held
24,995
-22.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#249
of 494 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Elevate Capital Advisors, LLC holds $1,338,434 across 2 Biotechnology names. ROIV ranks #1 (66.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
This page
|
24,995 | $884,573 | |
| 2 | DYN |
Dyne Therapeutics, Inc.
|
20,435 | $453,861 |
All Filings in ROIV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $884,573 | 24,995 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $890,555 | 32,150 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,682,726 | 77,545 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,721,506 | 113,781 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,307,613 | 116,026 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,789,905 | 177,394 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,115,830 | 178,853 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||